ID

19601

Beskrivning

Preoperative Bevacizumab and Trastuzumab With ABI-007 and Carboplatin in HER2+ Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00392392

Länk

https://clinicaltrials.gov/show/NCT00392392

Nyckelord

Versioner (1)
  1. 2017-01-14 2017-01-14 -
Uppladdad den

14 januari 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Breast Cancer NCT00392392

Engelsk

Eligibility Breast Cancer NCT00392392

1 Formulär  
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
female patients with histologically confirmed adenocarcinoma of the breast or inflammatory breast cancer
Beskrivning

Gender | Breast adenocarcinoma | Inflammatory Breast Carcinoma

Datatyp

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0858252
UMLS CUI [3]
C0278601
clinical stage t 1-4, n 0-3, m0
Beskrivning

TNM clinical staging

Datatyp

boolean

Alias
UMLS CUI [1]
C3258246
fish+ her2 gene amplified breast cancer
Beskrivning

Fluorescent in Situ Hybridization Positive | Breast Carcinoma HER2 gene amplification

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0162789
UMLS CUI [1,2]
C1514241
UMLS CUI [2,1]
C0678222
UMLS CUI [2,2]
C1512127
18 years or older
Beskrivning

Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
normal cardiac function
Beskrivning

Cardiac function

Datatyp

boolean

Alias
UMLS CUI [1]
C0232164
performance status 0-2
Beskrivning

performance status

Datatyp

boolean

Alias
UMLS CUI [1]
C1518965
cannot have received any prior chemotherapy for this disease or cannot have received chemotherapy for any other cancer in the past 5 years.
Beskrivning

Chemotherapy Disease | Chemotherapy Malignant Neoplasms

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0012634
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C0006826
previous diagnosis of noninvasive breast cancer is ok.
Beskrivning

Breast Carcinoma Non-invasive

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0205303
must have adequate bone marrow, renal and liver function.
Beskrivning

Bone Marrow function | Renal function | Liver function

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0232804
UMLS CUI [3]
C0232741
pregnant or lactating females not allowed.
Beskrivning

Pregnancy | Breast Feeding

Datatyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
preexisting peripheral neuropathy must be equal to or less than grade 1
Beskrivning

Peripheral Neuropathy Pre-existing CTCAE Grades

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0031117
UMLS CUI [1,2]
C2347662
UMLS CUI [1,3]
C1516728
must have archived tumor tissue for tissue testing.
Beskrivning

Tumor tissue sample Available Tissue analysis

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0475358
UMLS CUI [1,2]
C0470187
UMLS CUI [1,3]
C3161513
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
you cannot be in this study if you any of the following:
Beskrivning

Study Subject Participation Status Exclusion

Datatyp

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C2828389
history of cardiac disease, with new york heart association class ii or greater with congestive heart failure
Beskrivning

Heart Diseases | Congestive heart failure New York Heart Association Classification

Datatyp

boolean

Alias
UMLS CUI [1]
C0018799
UMLS CUI [2,1]
C0018802
UMLS CUI [2,2]
C1275491
any heart attack, stroke or tias within the last 6 months or serious arrhythmias needing medication; no bleeding diathesis or coagulopathy.
Beskrivning

Myocardial Infarction | Cerebrovascular accident | Transient Ischemic Attack | Cardiac Arrhythmia Serious Requirement Pharmaceutical Preparations | Bleeding tendency | Blood Coagulation Disorders

Datatyp

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2]
C0038454
UMLS CUI [3]
C0007787
UMLS CUI [4,1]
C0003811
UMLS CUI [4,2]
C0205404
UMLS CUI [4,3]
C1514873
UMLS CUI [4,4]
C0013227
UMLS CUI [5]
C1458140
UMLS CUI [6]
C0005779
no prior investigational drug within the last 30 days
Beskrivning

Investigational New Drugs

Datatyp

boolean

Alias
UMLS CUI [1]
C0013230
no prior trastuzumab or bevacizumab therapy
Beskrivning

trastuzumab | bevacizumab

Datatyp

boolean

Alias
UMLS CUI [1]
C0728747
UMLS CUI [2]
C0796392
there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons.
Beskrivning

Clinical Trial Eligibility Criteria Additional

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C1524062
Tillbaka till toppen

Similar models

Eligibility Breast Cancer NCT00392392

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Breast adenocarcinoma | Inflammatory Breast Carcinoma
Item
female patients with histologically confirmed adenocarcinoma of the breast or inflammatory breast cancer
boolean
C0079399 (UMLS CUI [1])
C0858252 (UMLS CUI [2])
C0278601 (UMLS CUI [3])
TNM clinical staging
Item
clinical stage t 1-4, n 0-3, m0
boolean
C3258246 (UMLS CUI [1])
Fluorescent in Situ Hybridization Positive | Breast Carcinoma HER2 gene amplification
Item
fish+ her2 gene amplified breast cancer
boolean
C0162789 (UMLS CUI [1,1])
C1514241 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2,1])
C1512127 (UMLS CUI [2,2])
Age
Item
18 years or older
boolean
C0001779 (UMLS CUI [1])
Cardiac function
Item
normal cardiac function
boolean
C0232164 (UMLS CUI [1])
performance status
Item
performance status 0-2
boolean
C1518965 (UMLS CUI [1])
Chemotherapy Disease | Chemotherapy Malignant Neoplasms
Item
cannot have received any prior chemotherapy for this disease or cannot have received chemotherapy for any other cancer in the past 5 years.
boolean
C0392920 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C0006826 (UMLS CUI [2,2])
Breast Carcinoma Non-invasive
Item
previous diagnosis of noninvasive breast cancer is ok.
boolean
C0678222 (UMLS CUI [1,1])
C0205303 (UMLS CUI [1,2])
Bone Marrow function | Renal function | Liver function
Item
must have adequate bone marrow, renal and liver function.
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
Pregnancy | Breast Feeding
Item
pregnant or lactating females not allowed.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Peripheral Neuropathy Pre-existing CTCAE Grades
Item
preexisting peripheral neuropathy must be equal to or less than grade 1
boolean
C0031117 (UMLS CUI [1,1])
C2347662 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,3])
Tumor tissue sample Available Tissue analysis
Item
must have archived tumor tissue for tissue testing.
boolean
C0475358 (UMLS CUI [1,1])
C0470187 (UMLS CUI [1,2])
C3161513 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Study Subject Participation Status Exclusion
Item
you cannot be in this study if you any of the following:
boolean
C2348568 (UMLS CUI [1,1])
C2828389 (UMLS CUI [1,2])
Heart Diseases | Congestive heart failure New York Heart Association Classification
Item
history of cardiac disease, with new york heart association class ii or greater with congestive heart failure
boolean
C0018799 (UMLS CUI [1])
C0018802 (UMLS CUI [2,1])
C1275491 (UMLS CUI [2,2])
Myocardial Infarction | Cerebrovascular accident | Transient Ischemic Attack | Cardiac Arrhythmia Serious Requirement Pharmaceutical Preparations | Bleeding tendency | Blood Coagulation Disorders
Item
any heart attack, stroke or tias within the last 6 months or serious arrhythmias needing medication; no bleeding diathesis or coagulopathy.
boolean
C0027051 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
C0007787 (UMLS CUI [3])
C0003811 (UMLS CUI [4,1])
C0205404 (UMLS CUI [4,2])
C1514873 (UMLS CUI [4,3])
C0013227 (UMLS CUI [4,4])
C1458140 (UMLS CUI [5])
C0005779 (UMLS CUI [6])
Investigational New Drugs
Item
no prior investigational drug within the last 30 days
boolean
C0013230 (UMLS CUI [1])
trastuzumab | bevacizumab
Item
no prior trastuzumab or bevacizumab therapy
boolean
C0728747 (UMLS CUI [1])
C0796392 (UMLS CUI [2])
Clinical Trial Eligibility Criteria Additional
Item
there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons.
boolean
C1516637 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial